Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000068

Chief Financial Officer sold 6,000 shares at an average $19.99 ($119,948)

  • Chief Financial Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2024-11-29 Option exercise 10b5-1 +1,000 $2.10 $2,100 74,849 D
WENTWORTH KORY JAMES Chief Financial Officer 2024-11-29 Sale 10b5-1 −1,000 $19.97 $19,970 73,849 D
WENTWORTH KORY JAMES Chief Financial Officer 2024-12-02 Option exercise 10b5-1 +5,000 $2.10 $10,500 78,849 D
WENTWORTH KORY JAMES Chief Financial Officer 2024-12-02 Sale 10b5-1 −5,000 $20.00 $99,978 73,849 D
Derivatives
WENTWORTH KORY JAMES Chief Financial Officer 2024-11-29 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,000 36,157 D
WENTWORTH KORY JAMES Chief Financial Officer 2024-12-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 31,157 D
Open-market sales · 6,000 sh · avg $19.99 · $119,948
Loading xslF345X05/wk-form4_1733264776.xml…